Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cornell Center for Tech., Enterprise, & Commerc.

Division of Cornell University
www.crf.cornell.edu

Latest From Cornell Center for Tech., Enterprise, & Commerc.

Deals Shaping the Medical Industry (02/2011)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions.

Avera Pharmaceuticals Inc.

Avera Pharmaceuticals Inc. is betting that there are enough promising neurological and psychiatric drugs gathering dust on the shelves of Big Pharma to support a substantial specialty business. It is starting out with a portfolio of neuromuscular blocker compounds acquired from GlaxoSmithKline PLC.
BioPharmaceutical Strategy

Cornell University

Cornell tries to turn Ithaca into a Cambridge-like hub of tech transfer.
See All
UsernamePublicRestriction

Register